F. La, Evolution de la perception de l'influence par les participants à, p.48

B. Mintzes, Comprendre la promotion pharmaceutique et y répondre Un manuel pratique. Traduction française en 2013[En ligne] 2009 [consulté le 20 mars 2016] Disponible sur internet :http://www.has-santé.fr 3. WOZNIAK L. Visiteurs médicaux : mais où sont-ils passés ? [Internet]. Les Généralistes-CSMF, 2017.

J. Cristofari and . Médecins-labos, Bien cerner les relations -[Internet]. [consulté le 16 juillet 2017]. Disponible sur internet <http://www.pharmaceutiques.com> 5. Chren MM. Interactions between physicians and drug company representatives, Am J Med, vol.107, issue.2, pp.182-185, 1999.

S. Chimonas, T. Brennan, and D. Rothman, Physicians and Drug Representatives: Exploring the Dynamics of the Relationship, Journal of General Internal Medicine, vol.81, issue.7, pp.184-90, 2007.
DOI : 10.7326/0003-4819-136-5-200203050-00014

M. Reeder, J. Dougherty, and L. White, Pharmaceutical representatives and emergency medicine residents: A national survey, Annals of Emergency Medicine, vol.22, issue.10, pp.1593-1599, 1993.
DOI : 10.1016/S0196-0644(05)81266-1

A. Fugh-berman and S. Ahari, Following the Script: How Drug Reps Make Friends and Influence Doctors. PLOS Medicine, p.150, 2007.
DOI : 10.1371/journal.pmed.0040150

URL : https://doi.org/10.1371/journal.pmed.0040150

E. Roughead, K. Harvey, and A. Gilbert, Commercial detailing techniques used by pharmaceutical representatives to influence prescribing, Australian and New Zealand Journal of Medicine, vol.18, issue.3, pp.306-316, 1998.
DOI : 10.1016/0277-9536(84)90160-6

M. Fischer, M. Keough, J. Baril, L. Saccoccio, K. Mazor et al., Prescribers and Pharmaceutical Representatives: Why Are We Still Meeting?, Journal of General Internal Medicine, vol.13, issue.1, 2009.
DOI : 10.7326/0003-4819-146-10-200705150-00008

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695530/pdf

D. Katz, A. Caplan, and J. Mertz, All Gifts Large and Small: Toward an Understanding of the Ethics of Pharmaceutical Industry Gift-Giving, The American Journal of Bioethics, vol.20, issue.10, pp.39-46, 2003.
DOI : 10.1097/00004010-199522000-00012

B. Goodman, Do drug company promotions influence physician behavior?, Western Journal of Medicine, vol.174, issue.4, pp.232-235, 2001.
DOI : 10.1136/ewjm.174.4.232

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1071337/pdf

. Charte-de-la-visite-médicale, Site Web du Ministère des Solidarités et de la Santé, 2016.

R. Adair and L. Holmgren, Do drug samples influence resident prescribing behavior? A randomized trial, The American Journal of Medicine, vol.118, issue.8, pp.881-885, 2005.
DOI : 10.1016/j.amjmed.2005.02.031

J. Boltri, E. Gordon, and R. Vogel, Effect of antihypertensive samples on physician prescribing patterns, Fam Med, vol.34, issue.10, pp.729-760, 2002.

D. Grande, D. Frosch, A. Perkins, B. Kahn, C. Essick et al., Effect of Exposure to Small Pharmaceutical Promotional Items on Treatment Preferences Medical school gift restriction policies and physician prescribing of newly marketed psychotropic medications: difference-in-differences analysis Prescrire Redaction - " Petits cadeaux : influence souvent inconsciente mais prouvée, Disponible sur internet, pp.887-93, 2009.

R. Marco, C. Moskop, J. Solomon, R. Geiderman, J. Larkin et al., Disponible sur internet: http://www.prescrire.org/fr 19Gifts to physicians from the pharmaceutical industry: an ethical analysis, Consulté le 15 juillet 2016], pp.31-694, 2006.

B. Mintzes, J. Lexchin, J. Sutherland, M. Beaulieu, M. Wilkes et al., Certification de la visite médicale :premier bilan ? Juillet Disponible sur internet : http://www.has.fr 25 Site Web de la Haute Autorité de santé Disponible sur internet: https://www.has-sante.fr/portail/upload/docs/application/pdf/2011-09/guide_es_vm.pdf 26 Pharmaceutical sales representatives and patient safety: a comparative prospective study of information quality in Canada, France and the United States, J Gen Intern Med, 2006.

D. Healy and D. Cattell, Interface between authorship, industry and science in the domain of therapeutics. The British Journal of Psychiatry, pp.22-29, 2003.

. J. Vailloud and . Le, gostwriting » ou l'écriture en sous-main des articles médicaux

A. Flanagin, L. Carey, and P. Fontanarosa, Prevalence of Articles With Honorary Authors and Ghost Authors in Peer-Reviewed Medical Journals, JAMA, vol.280, issue.3, pp.222-224, 1998.
DOI : 10.1001/jama.280.3.222

G. Mowatt, L. Shirran, and J. Grimshaw, Prevalence of Honorary and Ghost Authorship in Cochrane Reviews, JAMA, vol.287, issue.21, pp.2769-2771, 2002.
DOI : 10.1001/jama.287.21.2769

C. Deangelis and P. Fontanarosa, Impugning the Integrity of Medical Science, JAMA, vol.299, issue.15, pp.1833-1838, 2008.
DOI : 10.1001/jama.299.15.1833

R. Moynihan, Key opinion leaders: independent experts or drug representatives in disguise?, BMJ, vol.336, issue.7658, pp.1402-1405, 2008.
DOI : 10.1136/bmj.39575.675787.651

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2432185/pdf

S. Hensley and B. Martinez, New treatment : To selltheir drugs, companies increasingly rely on doctors. For $750 and up,physicianstell peers about products Leaders d'opinion : coûteux, mais rentables pour les firmes pharmaceutiques, Wall Street Journal Rev Prescrire, vol.25, issue.266, p.777, 2005.

J. Meffert, Key opinion leaders: where they come from and how that affects the drugs you prescribe, Dermatologic Therapy, vol.295, issue.16, pp.262-270, 2009.
DOI : 10.1111/j.1529-8019.2009.01240.x

M. Steinman, L. Bero, M. Chren, and C. Landefeld, Narrative Review: The Promotion of Gabapentin: An Analysis of Internal Industry Documents, Annals of Internal Medicine, vol.145, issue.4, pp.284-93, 2006.
DOI : 10.7326/0003-4819-145-4-200608150-00008

L. Delarue, La haute autorité de santé, tartuffe de l'indépendance, 2012.

. Available, Rapport d'information n°513-La prévention des conflits d'intérêts en matière d'expertise sanitaire [Internet]. [consulté le 16 juillet 2017] Disponible sur internet: https, these.pdf 41. Site Web du Sénat

D. Spence, Evidence based medicine is broken, BMJ, vol.348, issue.jan03 1, p.22, 2014.
DOI : 10.1136/bmj.g22

J. Lenzer, Why we can't trust clinical guidelines, BMJ, vol.346, issue.jun14 2, p.3830, 2013.
DOI : 10.1136/bmj.f3830

S. L. Spithoff, implication de l'industrie dans la formation médicale continue. Can Fam Physician, pp.700-703, 2014.

A. Bower and G. Burkett, Family physicians and generic drugs: a study of recognition, information sources, prescribing attitudes, and practices, J Fam Pract. Ferry ME, vol.24, issue.6, pp.612-618, 1987.

A. Gallini, R. Legal, and F. Taboulet, Influence des consommations de médiaments à l'hôpital sur les quantités consommées en ville. [ Internet] [consulté le 15 septembre 2017] Disponible sur internet : https://www.ces-asso.org/sites, Gallini_Legal.pdf 51. Site Web du LEEM. Marché mondial | LEEM -Les entreprises du médicament [Internet]. [Consulté le 6 août 2017]. Disponible sur internet

S. Web-du-leem-bilan-Économique, Disponible sur internet: http://www.leem.org/sites/default/files/Bilan%20%C3%A9conomique%202016_6.pdf 53. Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift?, pp.373-80, 2000.

M. Fischer and J. Avorn, Economic Implications of Evidence-Based Prescribing for Hypertension, JAMA, vol.291, issue.15, pp.1850-1856
DOI : 10.1001/jama.291.15.1850

E. Foisset, Etude de l'impact de la visite médicale sur la qualité des prescriptions des médecins généralistes bretons.Thèse de médecine générale ; Brest ; 2012 ; n°2912002 56

D. Disponible-sur-internet-https-korenstein, S. Keyhani, and J. Ross, Physician attitudes toward industry: a view across the specialties, Arch Surg, vol.145, issue.6, pp.570-577, 2010.

K. Austad, J. Avorn, A. Kesselheim, M. Steinman, M. Shlipak et al., Medical Students' Exposure to and Attitudes about the Pharmaceutical Industry: A Systematic Review [Internet]. [consulté le 16 juillet 2017].Disponible sur internet: http://journals.plos.org 59 Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions, Am J Med, 2001.

F. Sierles, A. Brodkey, L. Cleary, F. Mccurdy, M. Mintz et al., Medical Students??? Exposure to and Attitudes About Drug Company Interactions, JAMA, vol.294, issue.9
DOI : 10.1001/jama.294.9.1034

URL : http://jama.jamanetwork.com/data/journals/jama/4990/joc50088.pdf

D. Zipkin and M. Steinman, Interactions between pharmaceutical representatives and doctors in training, Journal of General Internal Medicine, vol.9, issue.suppl, pp.777-86, 2005.
DOI : 10.1111/j.1553-2712.2002.tb01585.x

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1490177/pdf

F. Montastruc, G. Moulis, A. Palmaro, V. Gardette, G. Durrieu et al., Interactions between Medical Residents and Drug Companies: A National Survey after the Mediator?? Affair, PLoS ONE, vol.42, issue.10, pp.104828-63, 2014.
DOI : 10.1371/journal.pone.0104828.s001

G. Moubarak, R. Martins, S. Zuily, A. Mechulan, and A. Guiot, [Frequency and type of gifts given by pharmaceutical industry to cardiology residents], Presse Med, pp.197-204, 2010.

B. Bégaud, D. Costagliola, L. Guittet, N. Weiss, V. Gajdos et al., Ministère des affaires sociales et de la santé Attitudes of Medical Students towards Conflict of Interest: A National Survey in France. PLOS ONE Site Web de la Haute Autorité de Santé -UE 1 : Apprentissage de l'exercice médical et de la coopération interprofessionnelle (1-20), Mar, vol.269, issue.3, pp.92858-66, 2014.

. Site-web-de-la-haute-autorité-de-santé-u12, Formation générale à la recherche 69 Site web de l'AMSA ? American Medical Student Association [Internet]. [consulté le 15 octobre 2016] Disponible sur internet: https://www.amsa.org/ 70, RIRE-Pourquoi garder son indépendance face aux laboratoires pharmaceutiques. Manuel [Internet]. La Troupe du RIRE. [consulté le 6 août 2017]. Disponible sur internet: https://latroupedurire.fr

B. Mccormick, G. Tomlinson, P. Brill-edwards, and A. Detsky, Effect of Restricting Contact Between Pharmaceutical Company Representatives and Internal Medicine Residents on Posttraining Attitudes and Behavior, JAMA, vol.286, issue.16, pp.1994-2003, 2001.
DOI : 10.1001/jama.286.16.1994

M. Wilkes and J. Hoffman, An Innovative Approach to Educating Medical Students about Pharmaceutical Promotion, Academic Medicine, vol.76, issue.12, pp.1271-1278, 2001.
DOI : 10.1097/00001888-200112000-00026

URL : http://pdfs.journals.lww.com/academicmedicine/2001/12000/An_Innovative_Approach_to_Educating_Medical.26.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1505289472656;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzd++Xw1xrBvVGm3URNugOVtUvOKGSkeb51J9diQu7Kn7kBPWybbz07NnkZDemRoyfi;hash|5E2ei64TPdNHiQzcRZ456g==

A. Stanley, D. Jackson, and D. Barnett, The teaching of drug development to medical students: collaboration between the pharmaceutical industry and medical school, British Journal of Clinical Pharmacology, vol.180, issue.4, pp.464-74, 2005.
DOI : 10.1136/bmj.326.7400.1202

J. Wofford, C. Ohl, R. Cialdini, W. Rice, and S. Serna, Teaching appropriate interactions with pharmaceutical company representatives: The impact of an innovative workshop on student attitudes Dispelling the illusion of invulnerability: the motivations and mechanisms of resistance to persuasion, BMC Med Educ Feb J Pers Soc Psychol, vol.85, 2002.

S. Kamal, C. Holmberg, J. Russell, T. Bochenek, B. Tobiasz-adamczyk et al., Perceptions ans attitudes of egyptian health professionnals and Policy-Makers towards Pharmaceutical Sales Representatives and other promotional activities, PLos ONE, vol.10, 2015.

K. Lieb and A. Scheurich, Contact between Doctors and the Pharmaceutical Industry, Their Perceptions, and the Effects on Prescribing Habits, PLoS ONE, vol.28, issue.10, 2014.
DOI : 10.1371/journal.pone.0110130.t003

S. Sinsard, Vision des laboratoires pharmaceutiques par des internes de médecine générale grenoblois. Thèse de médecine générale ; Grenoble, pp.2012-2025

N. Andresen, T. Olson, and M. Krasowski, Medical student and medical school teaching faculty perceptions of conflict of interest, BMC Research Notes, vol.110, issue.8
DOI : 10.1016/S0002-9343(01)00660-X

. Semestre-au-moment-du-cours, Stage effectués : Question 1 Perception générale Comment définiriez-vous l'industrie pharmaceutique ? Que vous évoque le terme industrie pharmaceutique? Cela a-t-il évolué depuis FACCRIP? Comment percevez-vous le rôle de l'industrie pharmaceutique ? Vous paraît-il instructif ?

L. Et-depuis and . Faccrip, Question 2 Perception des liens avec l'industrie pharmaceutique Comment décririez-vous aujourd'hui vos liens avec l'industrie pharmaceutique ?